ENSC
Ensysce Biosciences, Inc. Common Stock
stockNASDAQ
ensysce biosciences, san diego, ca, is an integrated drug delivery company for both small and large molecules. to overcome the major problem of non-medical use of opioid products, ensysce is using its prodrug technology to improve abuse deterrent properties. the tap bio-md™ abuse deterrent and mpar™ overdose resistant pain platforms, with worldwide intellectual patent protection, eliminate the ability to abuse opioid products by the non-oral route. this abuse is the fastest growing drug problem in the u.s. and it leads to billions in healthcare costs annually. for additional information about ensysce biosciences please visit www.ensysce.com.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 0.42 | 2026-10-30 | -21.28% | -0.204 |
| 1M | 0.43 | 2026-10-07 | -22.82% | 1.280 |
| 3M | 0.52 | 2026-08-07 | -36.29% | 0.693 |
| 6M | 0.37 | 2026-05-07 | -10.43% | 1.834 |
| 1Y | 2.06 | 2025-11-07 | -83.91% | 1.177 |
| 2Y | 10.44 | 2024-11-07 | -96.82% | — |
| 5Y | 8,028.00 | 2021-11-08 | -100.00% | 1.012 |
Ensysce Biosciences, Inc. Common Stock (NASDAQ:ENSC) stock price today is $0.33, and today's volume is 434,780. ENSC is down 8.199% today. The 30 day average volume is 493,877. ENSC market cap is $6.45M with 19.46M shares outstanding.